The Local Anesthetic Transperineal Prostate biopsy is associated with lower rates of infection and sepsis compared with the ...
Koelis, SAS ('Koelis” or the 'Company”, a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer interventions, announced today it is attending its 18th European Urology Meeting ...
URO-1, Inc. is a life sciences company dedicated to advancing the tools and workflows used in soft tissue biopsy diagnostics.
Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
The median fraction of the gland reaching ablative temperatures on intra-procedural MRI thermometry was 78% (IQR 71-85), with 68% of cases comprising whole gland ablation and 32% sub-total ablation: ...
First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...
Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26), taking place in London from 13–16 March 2026.
In a new study, researchers found microplastics deep inside prostate cancer tumors, raising more questions about the role the ubiquitous pollutants play in public health. The findings — which come ...
Procept BioRobotics today announced the international rollout of its next-generation Hydros robotic system for Aquablation therapy.
Prostate cancer often has no symptoms early on, but you may later have frequent urination, or blood in your urine or semen. Although less common, you may have painful ejaculation with prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results